Medtronic to Buy SPR Therapeutics for About $650M
Medtronic announced a $650 million cash acquisition of SPR Therapeutics, a maker of a temporary peripheral nerve stimulation device for chronic pain. The Sprint system, cleared by the FDA in 2018, has logged 50,000 implants through 2025 and offers up to 60 days of non‑permanent therapy. This purchase expands Medtronic’s neuromodulation portfolio, complementing earlier 2024 deals for Scientia Vascular ($550 million) and CathWorks (up to $585 million). The transaction is expected to close in the first half of fiscal 2027.
Medtronic Data Back Renal Denervation in the Long Term
Medtronic reported that two EuroPCR abstracts based on the global SYMPLICITY registry show its Symplicity Spyral renal denervation system delivers sustained blood‑pressure reductions over three years. One analysis of 787 patients with prior cardiovascular events recorded a 17.4 mmHg drop in office...
Endologix Buys Clot Removal System From Surmodics
Endologix announced the acquisition of the Pounce peripheral thrombectomy system from Surmodics for an undisclosed price. Pounce, cleared by the FDA in 2020 and expanded with a larger version in 2024, uses dual nitinol baskets and a funnel to mechanically...
Medtronic, BD Name New Leaders
Medtronic announced that Kweli Thompson, currently president of its cardiac rhythm management division, will become president of the company's neuroscience portfolio on June 1, succeeding Brett Wall, who will depart by Sept. 1 and resign from the MiniMed board in July. Scott Cundy, Medtronic’s...
Artivion Closes Endospan Buyout to Acquire Recently Approved Heart Device
Artivion completed its acquisition of Endospan by paying $131.3 million upfront for the Nexus Aortic Arch System, with up to $200 million in earn‑out payments tied to commercial success. The company estimates a $150 million annual U.S. addressable market for the minimally invasive,...
Boston Scientific Buys $1.5B Stake in TAVR Developer MiRus
Boston Scientific announced a $1.5 billion investment for a 34% equity stake in MiRus, the developer of a balloon‑expandable transcatheter aortic valve replacement (TAVR) system. The deal includes an exclusive option to acquire the remaining TAVR business for up to an...
Embecta Closes Owen Mumford Acquisition for up to $201M
Embecta closed its acquisition of UK‑based Owen Mumford for up to £150 million (about $201 million), shifting its focus from diabetes‑only products to a broader medical‑supplies portfolio. The deal includes a £100 million upfront payment and up to £50 million in performance‑based earn‑outs tied to...
Reinventing the Stethoscope and Cardiopulmonary Care
Eko Health, backed by Infineon, has launched the CORE 500 AI‑powered digital stethoscope, which pairs ultra‑low‑power PSoC 63 microcontrollers with advanced MEMS microphones to deliver real‑time heart‑sound analysis and three‑lead ECG. Clinical data from the TRICORDER trial show the device identifies heart...
Carl Zeiss Says Restructuring Could Affect up to 1,000 Jobs
Carl Zeiss Meditec announced a restructuring that could cut up to 1,000 jobs worldwide over the next three years. The move follows a 5.7% drop in first‑half revenue to €991 million (about $1.09 billion) and a fall in adjusted EBITDA to €60.5 million...
Labcorp Expands Epic Pact to Make Full Test Menu Available on Aura
Labcorp announced it will make its entire test menu available through Epic’s Aura platform, joining rivals such as Quest Diagnostics. The expansion builds on Labcorp’s 2023 acquisition of Invitae, which already used Aura for genetic testing. Aura lets clinicians order...
J&J Launches Improved Shockwave Catheter
Johnson & Johnson introduced the Shockwave C2 Aero, the fifth‑generation intravascular lithotripsy catheter designed to treat complex calcified coronary lesions. The new device offers greater flexibility and easier repositioning, expanding its use across a broader range of cases. It is already...
Artera Gets FDA Clearance for AI Breast Cancer Risk Prediction Tool
Artera, a 2023 startup backed by $90 million including Johnson & Johnson’s venture arm, received FDA clearance for its AI‑driven ArteraAI Breast tool. The system analyzes digitized pathology slides and clinical data to predict the likelihood of distant metastases in early‑stage, hormone‑receptor‑positive, HER2‑negative...
Medtronic to Close California Site Amid Restructuring
Medtronic announced it will shut its Santa Rosa, California, facility within the next two years, targeting a spring 2028 closure. The decision follows a global operations review and coincides with the creation of a new cardiovascular‑surgery unit that merges its...
Tandem to File Tubeless Insulin Pump with FDA This Quarter
Tandem Diabetes Care will file a 510(k) this quarter for a tubeless version of its Mobi insulin pump, aiming for FDA clearance in the second half of 2026. The company reported Q1 revenue of $247.2 million, a 5 % year‑over‑year increase, while...
Stryker Closes Amplitude Vascular Acquisition
Stryker completed its acquisition of Amplitude Vascular Systems, the developer of the Pulse intravascular lithotripsy (IVL) platform, within a month of announcing the deal, though financial terms remain undisclosed. The Pulse system uses carbon‑dioxide‑driven pressure waves to fracture calcium in...
FDA Warns of Neurosurgical Supply Disruptions
The FDA placed neurosurgical patties, sponges and strips on its medical device shortage list after Medline Industries recalled all of its neuro‑sponge products because of elevated endotoxin levels. The recall, classified as a Class 2 event, has created a nationwide shortage...
Neptune Medical’s GI Robot Succeeds in Colonoscopy Study
Neptune Medical’s Triton robotic endoscopy system cleared both primary endpoints in its first‑in‑human CARE 1 trial, demonstrating safety and feasibility for colonoscopy procedures. The single‑center study of 50 adults in Poland reported no adverse events and a 100% cecal intubation rate,...
Insulet Raises Revenue Expectations for 2026
Insulet Corp. raised its 2026 revenue growth outlook to 21%‑23% on a constant‑currency basis, up from the prior 20%‑22% range. The company posted Q1 revenue of $761.7 million, a 34% year‑over‑year increase, and net income of $91.1 million. Growth is being driven...
J&J’s Ottava Robot Meets Goals in Gastric Bypass Study
Johnson & Johnson reported that its investigational Ottava robotic system met safety and efficacy endpoints in a 30‑patient gastric bypass study, achieving an average 30‑pound weight loss within 30 days and no device‑related adverse events. All procedures were completed robotically...
Integra Reappoints Stuart Essig as CEO
Integra LifeSciences announced the reappointment of former chief executive Stuart Essig, ending the brief tenure of Mojdeh Poul. Essig returns after a 14‑year gap and will be supported by newly created chief commercial officer Michael McBreen. The leadership team says...
Mobia Medical Plans IPO
Mobia Medical announced the terms of its initial public offering, targeting up to $155 million by selling 10 million shares at $14‑$16 each. The company expects net proceeds of about $134.5 million, with an additional $20.9 million possible if underwriters exercise their option. Approximately...
Edwards Names Theodora Mistras as CFO
Edwards Lifesciences announced Theodora “Doretta” Mistras will become its chief financial officer effective end of May, succeeding long‑time CFO Scott Ullem who will stay on as a strategic adviser. Mistras comes from a two‑year stint as CFO of Viatris and...
Olympus, EndoRobotics Forge Distribution Pact
Olympus announced an exclusive global distribution agreement with South Korea‑based EndoRobotics to sell its endoscopic robotic devices, starting in the United States and expanding the company’s EndoTherapy portfolio. The deal covers the Robopera console, articulated grippers, a scope‑mounted traction device,...
Top Medtech Executive Moves in 2026
The medtech sector saw a wave of executive reshuffles in early 2026, highlighted by José Almeida moving from Baxter to lead Hologic after the women’s‑health firm went private in an $18.3 billion deal. Teleflex tapped longtime Medtronic executive Jason Weidman as CEO while...
Stryker Cyberattack ‘Meaningfully’ Impacted Q1
Stryker reported first‑quarter sales of $6 billion, a 2.6% year‑over‑year increase that fell short of its typical 10‑12% growth pace. The slowdown stems from a March 11 cyberattack that shut down ordering, shipping and manufacturing for several weeks, wiping 40,000 laptops...
Teleflex Hires Jason Weidman as CEO
Teleflex announced that Jason Weidman, a two‑decade Medtronic veteran who most recently led its coronary and renal denervation business, will become president and CEO on June 8. The appointment comes as Teleflex moves to divest its acute‑care, interventional urology and OEM...
FDA Advises Users of Trividia Glucometer to Switch to Alternatives
The FDA has issued a safety communication urging all users of Trividia Health’s True Metrix glucometer to switch to alternative blood‑glucose testing methods. The recommendation follows an error‑code flaw that displays the same E‑5 code for dangerously high glucose levels...
Medtronic Wins FDA Approval for Updated Mitral Replacement Valve
Medtronic announced FDA approval for its next‑generation Mosaic Neo bioprosthetic mitral valve and has begun U.S. launches. The valve can be implanted via traditional sternotomy or minimally invasive approaches, and the company performed the first combined implant with its Penditure left‑atrial‑appendage...
Surgeries Are Moving to ASCs. Distalmotion Wants Its Robot to Drive the Shift.
Distalmotion, a Swiss medtech spinoff, is targeting the rapid migration of low‑risk surgeries to ambulatory surgery centers (ASCs) with its Dexter robotic system. The robot, cleared by the FDA for inguinal hernia, gallbladder removal and hysterectomy, offers a compact 125‑sq‑ft...
Zimmer Biomet CFO Departs for New Job
Zimmer Biomet’s chief financial officer, Suketu Upadhyay, is leaving after seven years to become CFO of biotech firm Incyte. The orthopedics maker named controller Paul Stellato as interim CFO while it searches for a permanent replacement. In its first quarter,...
Medtronic Reports Data Breach on Corporate IT Systems
Medtronic disclosed an unauthorized access to its corporate IT systems but said the breach did not affect product, manufacturing or patient‑care networks. The company activated its incident‑response plan, engaged external cybersecurity experts, and is reviewing whether personal data was exposed....
J&J to Acquire Atraverse Medical
Johnson & Johnson announced it will acquire Atraverse Medical, the developer of the FDA‑cleared Hotwire radio‑frequency guidewire for atrial fibrillation ablation. Atraverse has performed nearly 3,000 left‑heart access procedures, with 29% done fluoroscopy‑free and a 100% success rate in early...
With Ultrasound on a Chip, Butterfly Network Aims for Global Reach
Butterfly Network, under CEO Joe DeVivo, is scaling its chip‑based handheld ultrasound priced around $4,000 to make imaging affordable and portable worldwide. The device replaces costly cart‑based machines ($30,000‑$200,000) with a probe containing 9,000 sensors and AI‑enhanced modes, and the...
Edwards Raises 2026 Forecast as TAVR Sales Surge
Edwards Lifesciences raised its full‑year 2026 sales‑growth outlook to 9‑11% after reporting a 16.7% jump in first‑quarter revenue to $1.65 billion, driven by a 14.4% increase in TAVR sales to $1.2 billion. The company also lifted its TAVR growth forecast to 7‑9%...
J&J Lands CE Mark for Surgical Stapler that Works with Ottava Robot
Johnson & Johnson has secured a CE mark for its Ethicon 4000 surgical stapler, enabling European surgeons to use the device in open and laparoscopic procedures now. The stapler is engineered to work with J&J’s upcoming Ottava robotic platform, which has...
Tandem Recalls Mobi Insulin Pumps over Software Malfunction
Tandem Diabetes Care issued a Class I recall for its Mobi insulin pump after a software defect was found to falsely detect motor failure, stopping insulin delivery and cutting communication with continuous glucose monitors and the mobile app. The FDA’s enforcement...
CDRH Director Tarver Previews AI Guidance at AAMI Event
At the AAMI neXus conference, FDA CDRH Director Michelle Tarver announced that final guidance on AI lifecycle management will be issued later this year, building on the draft released in January 2025. The guidance will codify requirements for representative training...
Boston Scientific Slashes 2026 Guidance
Boston Scientific reported first‑quarter revenue of $5.2 billion, up 11.6% year‑over‑year, and net income of $1.34 billion, double the prior year. The company trimmed its 2026 sales growth outlook to 7%‑8.5% and adjusted EPS guidance to $3.34‑$3.41, down from the February ranges....
Intuitive Surgical Lifts 2026 Outlook for Da Vinci Robot Procedure Growth
Intuitive Surgical reported a strong first quarter, posting $2.77 billion in revenue, a 23% year‑over‑year increase, and $822 million net income. Da Vinci robot placements rose to 431, driving a 16% rise in procedures and prompting the company to lift its 2026 outlook...
MiniMed Posts Double-Digit Sales Growth, Widening Net Loss
MiniMed, Medtronic’s diabetes‑tech spinoff, posted FY26 Q3 revenue of $790 million, up 15 % year‑over‑year, but its net loss widened dramatically to $119 million from $10 million a year earlier. Growth was driven by sales of its automated insulin‑delivery system, FDA clearance for the...
Medtronic Closes $585M Purchase of CathWorks
Medtronic announced the closing of its $585 million acquisition of CathWorks, bringing the AI‑driven FFRangio system into its cardiovascular portfolio. The purchase follows a February agreement and includes potential earn‑out payments. It is part of an accelerated M&A strategy that also...
RFK Jr. Defends HHS Tenure, 12% Proposed Budget Cut
Health and Human Services Secretary Robert F. Kennedy Jr. defended his tenure and the Trump administration’s FY2027 budget proposal that would slash HHS discretionary spending by 12.5%, roughly $16 billion. The plan includes a $5 billion cut to NIH and a $4 billion...
LTS Lohmann Builds a Foundation for Proactive Quality and Innovation
LTS Lohmann Therapy Systems is overhauling its quality management by deploying a unified, enterprise‑wide QMS and advanced data analytics. The new platform eliminates manual bottlenecks and data fragmentation, delivering real‑time traceability and AI‑ready insights across all sites. By partnering with...
From Imaging to Understanding, How Real-Time 3D Is Evolving the Clinic of the Future
Barco and Avatar Medical unveiled Eonis Vision, a glasses‑free, real‑time 3D imaging system that turns CT and MRI scans into lifelike, floating models during patient consultations. The solution runs on Dell Pro Precision workstations powered by NVIDIA RTX PRO GPUs, delivering...
Siemens Plans Shareholder Vote on Siemens Healthineers Spinoff
Siemens announced it will ask shareholders to vote on a plan to spin off Siemens Healthineers at the February annual meeting. The proposal would transfer 30% of Healthineers shares to Siemens investors, reducing the parent’s stake from 67% to roughly...
GE HealthCare, RadNet Expand AI Mammography Collaboration
GE HealthCare is widening its AI mammography partnership with RadNet subsidiary DeepHealth, adding more artificial‑intelligence tools to its Pristina Via system. The expanded pact introduces features such as cancer detection, automated density assessment, and lesion localization, plus an optional secondary‑review...
Abbott Lowers Earnings Forecast After $21B Exact Sciences Buy
Abbott lowered its 2026 adjusted EPS forecast to $5.38‑$5.58 after completing a $21 billion acquisition of Exact Sciences. The deal adds Exact’s Cologuard colorectal‑cancer screening test, which Abbott expects to generate about $3 billion in incremental sales this year. Q1 revenue rose...
Boston Scientific Plans $88.5M R&D Expansion in Ireland
Boston Scientific announced a €75 million (≈ $88.5 million) investment to expand its Galway, Ireland R&D campus, concentrating on cardiovascular innovation. The upgrade will add advanced laboratories for structural‑heart, heart‑failure and renal‑denervation programs. The Irish government, via IDA Ireland, will provide financial support...
Medtronic Confirms Paclitaxel Balloon’s Efficacy in Post-Approval Trial
Medtronic reported that its IN.PACT AV paclitaxel‑coated balloon achieved a 70.2% target lesion patency rate at 12 months in a post‑approval study of end‑stage kidney disease patients. This figure mirrors the 65.3% rate observed in the pivotal trial that secured FDA...
Stereotaxis to Buy Robocath for up to $45M
Stereotaxis announced it will acquire French robotic‑surgery firm Robocath for up to $45 million, paying $20 million upfront and up to $25 million contingent on milestones such as FDA clearance of Robocath’s next‑generation system. The deal merges Stereotaxis’s magnetic navigation platform with Robocath’s...